Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 664 (106th)

Prescription Drug Fairness for Seniors Act of 1999

openUnited States· United States Congress· EN

Introduced

10 February 1999

Last action

17 July 2000 · Introduced

Status

Sponsor introductory remarks on measure. (CR H6099-6102)

Sponsors

Rep. Allen, Thomas H. [D-ME-1], Rep. Turner, Jim [D-TX-2], Rep. Waxman, Henry A. [D-CA-33], Rep. Berry, Marion [D-AR-1], Rep. Stark, Fortney Pete [D-CA-13], Sen. Sanders, Bernard [I-VT], Rep. Capps, Lois [D-CA-24], Rep. Tierney, John F. [D-MA-6], Rep. Lampson, Nick [D-TX-22], Sen. Stabenow, Debbie [D-MI], Rep. Davis, Danny K. [D-IL-7], Rep. Kennedy, Patrick J. [D-RI-1], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Wexler, Robert [D-FL-19], Rep. Frost, Martin [D-TX-24], Rep. McGovern, James P. [D-MA-2], Rep. Cummings, Elijah E. [D-MD-7], Rep. Thompson, Bennie G. [D-MS-2], Rep. Sandlin, Max [D-TX-1], Rep. Ford, Harold E., Jr. [D-TN-9], Sen. Brown, Sherrod [D-OH], Rep. Weygand, Robert A. [D-RI-2], Rep. Kilpatrick, Carolyn C. [D-MI-13], Rep. Pomeroy, Earl [D-ND-At Large], Rep. Borski, Robert A. [D-PA-3], Rep. Olver, John W. [D-MA-1], Rep. Thurman, Karen L. [D-FL-5], Rep. Blumenauer, Earl [D-OR-3], Rep. Serrano, Jose E. [D-NY-15], Rep. Baldacci, John Elias [D-ME-2], Rep. Matsui, Robert T. [D-CA-5], Rep. Delahunt, William D. [D-MA-10], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Hooley, Darlene [D-OR-5], Rep. McCarthy, Carolyn [D-NY-4], Rep. Cramer, Robert E. (Bud), Jr. [D-AL-5], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Frank, Barney [D-MA-4], Rep. Andrews, Robert E. [D-NJ-1], Rep. Meehan, Martin T. [D-MA-5], Rep. Filner, Bob [D-CA-51], Rep. Kleczka, Gerald D. [D-WI-4], Rep. Barrett, Thomas M. [D-WI-5], Rep. Stupak, Bart [D-MI-1], Rep. Abercrombie, Neil [D-HI-1], Rep. Ackerman, Gary L. [D-NY-5], Rep. Luther, Bill [D-MN-6], Rep. Pallone, Frank [D-NJ-6]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Summary

Prescription Drug Fairness for Seniors Act of 1999 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy such covered outpatient drug in the described amount (an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries) and at the described price (the price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug). Sets forth special provisions with respect to hospice programs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 10 February 1999

    Introduced

    Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 10 February 1999

    Introduced

    Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 10 February 1999

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 10 February 1999

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 11 February 1999

    Introduced

    Sponsor introductory remarks on measure. (CR H628, H631)

    Source: IntroReferral

  6. 22 February 1999

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  7. 11 March 1999

    Referred

    Referred to the Subcommittee on Health and Environment.

    Source: Committee

  8. 19 May 1999

    Introduced

    Sponsor introductory remarks on measure. (CR H3363-3370)

    Source: IntroReferral

  9. 22 September 1999

    Introduced

    Sponsor introductory remarks on measure. (CR H8540-8546)

    Source: IntroReferral

  10. 27 September 1999

    Introduced

    Sponsor introductory remarks on measure. (CR H8831)

    Source: IntroReferral

  11. 15 February 2000

    Introduced

    Sponsor introductory remarks on measure. (CR H418-419, H425)

    Source: IntroReferral

  12. 19 June 2000

    Introduced

    Sponsor introductory remarks on measure. (CR H4659-4661, H4661-4662)

    Source: IntroReferral

  13. 17 July 2000

    Introduced

    Sponsor introductory remarks on measure. (CR H6099-6102)

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 10 February 1999

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 10 February 1999

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 10 February 1999

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 156 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.